Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design by Sushant B. Jadhav Rahul M. Mane Kalyanraman L. Narayanan & Popatrao N. Bhosale

Author:Sushant B. Jadhav, Rahul M. Mane, Kalyanraman L. Narayanan & Popatrao N. Bhosale
Format: pdf
Tags: A novel, stability indicating, reverse phase high-performance liquid chromatography (RP-HPLC) method was developed to determine the S-isomer of linagliptin (LGP) in linagliptin and metformin hydrochloride (MET HCl) tablets (LGP–MET HCl) by implementing design of experiment (DoE), i.e., two-level, full factorial design (23 + 3 centre points = 11 experiments) to understand the critical method parameters (CMP) and its relation with the critical method attribute (CMA), and to ensure robustness of the method. The separation of the S-isomer, LGP and MET HCl in the presence of their impurities was achieved on Chiralpak® IA-3 (Amylose tris (3, 5-dimethylphenylcarbamate), immobilized on 3 m silica gel) stationary phase (250 4.6 mm, 3 m) using isocratic elution and detector wavelength at 225 nm with a flow rate of 0.5 mLmin-1, an injection volume of 10 L with a sample cooler (5 C) and column oven temperature of 25 C. Ethanol:Methanol:Monoethanolamine (EtOH:MeOH:MEA) in the ratio of 60:40:0.2 v/v/v was used as a mobile phase. The developed method was validated in accordance with international council for harmonisation (ICH) guidelines and was applied for the estimation of the S-isomer of LGP in LGP–MET HCl tablets. The same method also can be extended for the estimation of the S-isomer in LGP dosage forms., S-isomer; enantiomer; design of experiments (DoE); development; linagliptin and metformin hydrochloride


Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.